Ranbaxy moves court to halt Elder's 'ride' on pain-reliever brand Volini
This article was originally published in Scrip
Executive Summary
Ranbaxy Laboratories has initiated legal action against Elder Pharmaceuticals charging the latter with deliberately trying to "ride" on its reputation in a case concerning Ranbaxy's top-selling OTC topical pain-reliever brand, Volini.